Clinical trial
Regimen Education and Messaging in Diabetes (REMinD)
NCT03185741
Study timeline
Study start (actual)2018-01-05Date precision: day
Registry last updated2023-03-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Medication Adherenceunresolved
Interventions
UMS StrategyBEHAVIORAL
SMS Text MessagingBEHAVIORAL
Sponsors & collaborators
Northwestern Universitylead sponsor
Icahn School of Medicine at Mount Sinaicollaborator
Emory Universitycollaborator
Northwestern Memorial Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03185741 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.